330 related articles for article (PubMed ID: 24283840)
21. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
22. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
[TBL] [Abstract][Full Text] [Related]
23. Self-reported adverse reactions to subcutaneous airborne allergen immunotherapy: a real-life, single center study.
Pereira AM; Pereira M; Araújo LM; Castel-Branco MG; Morete A; Almeida Fonseca J
Eur Ann Allergy Clin Immunol; 2023 May; 55(3):131-140. PubMed ID: 33949174
[No Abstract] [Full Text] [Related]
24. Analysis of an unusual cluster of systemic reactions to subcutaneous specific immunotherapy with respiratory allergens in one allergy center.
Scherer K; Schindler C; Arnold A; Bach S; Bircher AJ
Int Arch Allergy Immunol; 2012; 157(3):318-20. PubMed ID: 22056648
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
Erekosima N; Suarez-Cuervo C; Ramanathan M; Kim JM; Chelladurai Y; Segal JB; Lin SY
Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632
[TBL] [Abstract][Full Text] [Related]
27. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
[TBL] [Abstract][Full Text] [Related]
28. Local and systemic reactions to subcutaneous allergen immunotherapy: Ten years' experience in a pediatric clinic.
Nacaroglu HT; Erdem SB; Sumer O; Karaman S; Unsal Karkıner CS; Asilsoy S; Gunay I; Can D
Ann Allergy Asthma Immunol; 2016 Apr; 116(4):349-53. PubMed ID: 26905639
[TBL] [Abstract][Full Text] [Related]
29. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and adverse reactions to subcutaneous immunotherapy in children with allergic rhinitis/asthma.
Duman Senol H; Topyildiz E; Ekici B; Gulen F; Demir E
Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111292. PubMed ID: 36007303
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
32. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.
Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D
Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754
[TBL] [Abstract][Full Text] [Related]
33. New forms of allergy immunotherapy for rhinitis and asthma.
Nelson HS
Allergy Asthma Proc; 2014; 35(4):271-7. PubMed ID: 24992546
[TBL] [Abstract][Full Text] [Related]
34. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
[TBL] [Abstract][Full Text] [Related]
35. Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application.
Ullrich D; Ullrich K; Mussler S; Thum-Oltmer S
Eur Ann Allergy Clin Immunol; 2015 Jan; 47(1):10-4. PubMed ID: 25599553
[TBL] [Abstract][Full Text] [Related]
36. Diurnal variations in subcutaneous allergen immunotherapy reactions.
Bavishi AA; Grammer LC; Pongracic J; Rychlik K; Kumar R; Zee P; Greenberger PA; Fishbein AB
Ann Allergy Asthma Immunol; 2017 Jan; 118(1):103-107. PubMed ID: 27864091
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
38. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
39. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
Bernstein DI; Epstein TEG
Allergy Asthma Proc; 2020 Mar; 41(2):108-111. PubMed ID: 32122446
[TBL] [Abstract][Full Text] [Related]
40. Safety of inhalant allergen immunotherapy with mass units-standardized extracts.
Nettis E; Giordano D; Pannofino A; Ferrannini A; Tursi A
Clin Exp Allergy; 2002 Dec; 32(12):1745-9. PubMed ID: 12653166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
